Clinical trials
Completed Observational Peripheral Arterial Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
189 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 7 |
| 2011 | 13 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 13 |
| 2017 | 12 |
| 2018 | 17 |
| 2019 | 12 |
| 2020 | 16 |
| 2021 | 10 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 189 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Angers | 8 |
| C. R. Bard | 7 |
| Bayer | 5 |
| Biotronik AG | 5 |
| Abbott Medical Devices | 3 |
| Spectranetics Corporation | 3 |
| University College, London | 3 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| be Medical | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 189 |
| Chronic Limb-Threatening Ischemia | 19 |
| Intermittent Claudication | 19 |
| Peripheral Vascular Diseases | 18 |
| Cardiovascular Diseases | 16 |
| Coronary Artery Disease | 15 |
| Atherosclerosis | 12 |
| Diabetes Mellitus | 12 |
| Myocardial Infarction | 9 |
| Stroke | 9 |
Trials
Showing 1 to 25 of 189. Each trial links to its page on Pharma Observatory.
89 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.